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Abstract: Stroke is the leading cause of disability in developed countries and the third cause of mortality. Up to 15-30% 
of ischemic strokes are caused by cardiac sources of emboli being associated with poor prognosis and high index of fatal 
recurrence. In order to establish an adequate preventive strategy it is crucial to identify the cause of the embolism. After a 
complete diagnostic workup up to 30% of strokes remain with an undetermined cause, and most of them are attributed to 
an embolic mechanism suggesting a cardiac origin.  
There is no consensus in the extent and optimal approach of cardiac workup of ischemic stroke. Clinical features along 
with brain imaging and the study of the cerebral vessels with ultrasonography or MRI/CT based angiography can identify 
other causes or lead to think about a possible cardioembolic origin.  
Atrial fibrillation is the most common cause of cardioembolic stroke. Identification of occult atrial fibrillation is essential. 
Baseline ECG, serial ECG(’s), cardiac monitoring during the first 48 hours, and Holter monitoring have detection rates 
varying from 4 to 8% each separately. Extended cardiac monitoring with event loop recorders has shown higher rates of 
detection of paroxysmal atrial fibrillation.  
Cardiac imaging with echocardiography is necessary to identify structural sources of emboli. There is insufficient data to 
determine which is the optimal approach. Transthoracic echocardiography has an acceptable diagnostic yield in patients 
with heart disease but transesophageal echocardiography has a higher diagnostic yield and is necessary if no cardiac 
sources have been identified in patients with cryptogenic stroke with embolic mechanism.  
Keywords: Ambulatory electrocardiography, atrial fibrillation, cardiac workup, cardioembolic stroke, cryptogenic stroke, 
echocardiography, electrocardiography, stroke. 
INTRODUCTION 
  Stroke is the major cause of serious long-term disability 
and the third cause of death in developed countries [1]. More 
than 5 million people die of stroke every year and 1 out of 6 
survivors will suffer another stroke in the next 5 years, the 
majority of them during the first year. Stroke rates in the 
USA reach 700 000 cases/year with 170 000 dying after 
consequence of its effects [2]. Incidence rates in European 
countries are around 1.5-2/1000 cases per year [3,4]. The 
recurrence rate can be as high as 30% and the mortality of 
recurrences is two-fold [5,6]. 
  Ischemic stroke accounts for about 70-80% of all strokes 
and is caused by embolic or thrombotic occlusions in the 
cerebral vessels. Embolic occlusions can be of arterial or 
cardiac origin. The etiology of ischemic stroke is mainly due 
to large artery atherosclerosis, from cardiac sources of 
embolism in approximately 30% of cases and small vessel 
disease leading to lacunar infarction, but a significant num-
ber of cases remain undetermined after a diagnostic approach 
[7]. 
  Strokes due to cardiac embolism are generally associated 
with poor prognosis. Cardioembolic stroke has been asso-
ciated with short and long-term recurrence, higher in- 
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hospital mortality and a higher index of fatal recurrence 
versus other causes of stroke [7-9]. 
  Identification of the specific cause is crucial in order to 
choose the most optimal preventive strategy and these vary 
for the different subtypes of ischemic stroke. 
  Depending on the extent of diagnostic evaluation and the 
criteria employed, 15-30% of ischemic strokes can be attri-
buted to an identifiable source of cardiac embolism. 
  Searching for cardiac sources of stroke is a crucial part of 
the urgent ischemic stroke evaluation as it will change treat-
ment decisions. There is a considerable disagreement among 
experts regarding the extent of cardiac testing in stroke 
patients. There is insufficient data to support the optimal 
cost-effective approach.  
  Even after a complete diagnostic workup up to 30% of all 
strokes remain classified as undetermined or cryptogenic. 
Most of these have embolic features [10] and an occult 
cardiac source is suspected in most cases. 
PATHOPHYSIOLOGY AND MECHANISMS 
  It is important to differentiate ischemic stroke from 
hemorrhagic stroke. Ischemic stroke is originated by an 
interruption of cerebral blood flow as a result of an arterial 
occlusion, while the rupture of a blood vessel causes hemorr-
hagic stroke. Ischemic stroke is by far the most common and 
its underlying mechanisms and causes are multiple. 176    Current Cardiology Reviews, 2010, Vol. 6, No. 3  Ustrell and Pellisé 
  The brain receives 15% of cardiac output and is 
extremely sensitive to ischemia. There is general agreement 
that embolism from arterial, cardiac or unknown sources is 
the most frequent mechanism although thrombosis, in small 
vessel disease originating lacunar infarction and hemo-
dynamic infarctions due to hypoperfusion in border artery 
territories are common and accepted mechanisms. 
  Material dislodged in close proximity to great vessels can 
travel to the cerebral arteries and occlude cerebral vessels 
with abrupt neurological manifestations. The embolic 
material is thrombus and tends to occlude cerebral artery 
stems, while emboli of small size and different compositions 
like fat, air or cholesterol crystals tend to travel to smaller 
terminal branches leading to watershed infarction. 
DIAGNOSTIC PROCEDURE 
  Ischemic stroke is a heterogeneous disease with different 
mechanisms and etiologies and specific treatments. Identifi-
cation of the right cause is essential in order to prepare an 
adequate preventive strategy. 
  Ischemic stroke is mainly classified into 5 main subtypes: 
atherotrombotic, cardioembolic, lacunar, uncommon and 
cryptogenic stroke.  
  An arterial embolic occlusion, from an arterial stenosis 
originated by great vessel disease, usually causes athero-
trombotic stroke although hemodynamic stroke caused by 
hypoperfusion in watershed territories and occlusion by 
thrombosis can also occur. Cardioembolic stroke is caused 
by emboli from a cardiac or aortic source. Lacunar stroke is 
caused by occlusion by lipohyalinosis of terminal penetrant 
arteries, small vessel disease. Stroke from uncommon cause 
is another subtype originated by less frequent disorders such 
as arterial dissection, coagulopathy, disinmune disorders, 
drug abuse, etc. Ultimately stroke is classified as cryptogenic 
or undetermined when no cause is identified after a thorough 
study.  
  The first step after a clinically defined stroke is to rule 
out a brain hemorrhage with brain imaging techniques such 
as magnetic resonance imaging (MRI) or computed 
tomography (CT). After the confirmation of an ischemic 
stroke all the clinical and complementary studies are directed 
to find out the cause of the stroke.  
  In many patients medical history, risk factor profile, 
physical exploration, and basic explorations (ECG and 
thorax x-ray) may already indicate or suggest some specific 
causes such as the presence of carotid bruits originated by a 
carotid stenosis, rheumatic or prosthetic valve disease and 
atrial fibrillation. 
  If no etiology is found the next step is usually directed 
towards identifying arterial causes of embolism using ultra-
sound techniques, transcranial Doppler (TCD) and cervical 
arteries Doppler (CD), color coded transcranial or cervical 
arteries duplex (TCCD, CCD) or angiography, usually MRI 
or CT based, of the intracranial and cervical vessels. 
  When an embolic source is suspected and great vessel 
disease has been ruled out, it is common practice to start 
cardiac explorations to identify a cardiac source of stroke. 
The depth of these studies varies among centers and remains 
a subject of debate among the different fields dedicated to 
the study of stroke. 
DIAGNOSIS OF CARDIOEMBOLIC STROKE 
  Diagnosis of cardioembolic infarction depends on suspi-
cion by clinical, neuroimaging and laboratory features   
(Table 1).  
Table 1.  Features Suggestive of Cardioembolic Stroke 
Clinical 
Sudden onset to maximal deficit 
Rapid regression of symptoms 
Visual field defect, neglect or aphasia 
Concomitant palpitations or oppressive chest pain 
MRI or CT 
Simultaneous or sequential infarcts in different arterial territories 
Hemorrhagic transformation 
Hyperdense artery sign in absence of arterial pathology 
Ultrasound 
Occlusion of the carotid artery by a mobile thrombus 
Early recanalisation of an arterial occlusion 
Microembolism (HITS) in both middle cerebral arteries 
Laboratory 
Elevation of troponins or cardiac enzymes 
Brain natriuretic peptide 
 
  The definite diagnosis of cardioembolic stroke relies on 
identification of cardiac sources of emboli caused by abnor-
malities of cardiac rhythm or structure using electocar-
diographic monitoring and cardio-aortic imaging. 
CLINICAL SYMPTOMS AND SIGNS 
  Cardiac emboli can travel along to the intracranial vessels 
and due to their variable size cause either massive infarcts by 
occlusion of proximal arteries, small superficial infarcts in 
distal arterial territories, single large deep infarcts or multiple 
infarcts in different arterial territories. 
  Clinical presentation is characterized by sudden neurolo-
gical deficits maximal at onset due to abrupt interruption of 
blood flow. While a stuttering course has usually been 
attributed to atherothrombotic stroke, cardioembolic emboli 
can have a progressive course in at least one-fifth of cases 
given that emboli can recanalise, move and fragment after 
initial impaction. Noncardioembolic strokes can appear with 
sudden deficits in two-fifths of cases [11,12]. Rapid regres-
sion of symptoms (the spectacular shrinking syndrome) 
reflecting early recanalisation has also been related to 
cardioembolic stroke [13]. 
  Some neurological syndromes such as Wernicke’s apha-
sia, global aphasia without hemiparesis, Wallenberg’s syn-
drome, cerebellar infarcts, top-of-the basilar artery syndrome 
have been commonly associated with cardiac embolism [14]. 
Visual-field abnormalities, neglect and aphasia are clinical 
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logical deficits and syndromes may indicate embolic mecha-
nisms but all have suboptimal discriminatory capacity [14].  
NEUROIMAGING 
  Brain imaging is key to identify cerebral infarcts and to 
distinguish hemorrhagic stroke. Imaging techniques of the 
brain parenchyma are useful to rule out lacunar stroke caused 
by small vessel disease. Neuroimaging can help to diagnose 
cardioembolic stroke by revealing characteristic patterns of 
ischemic lesions associated to an embolic mechanism from a 
cardiac source. 
  Cardiac emboli often occlude middle-large size arteries 
and multiple vascular territories. Hemorrhagic transfor-
mation of an ischemic infarct and early recanalisation of an 
arterial occlusion are typical characteristics related to cardiac 
embolisms [16,17]. 
  Simultaneous or sequential strokes in different arterial 
territories, especially if bihemispheric, combining anterior 
and posterior circulation or with concurrent systemic embo-
lism are highly suggestive features of a cardiac source of 
embolism [11,14,18]. The identification of cortical involve-
ment is characteristic of an embolic mechanism. 
  MRI has demonstrated to be clearly superior to CT in 
identifying ischemic lesions not visible on CT and has the 
capacity to detect cerebral ischemia within minutes of onset 
by diffusion-weighted sequences (DWI) [19]. MRI is 
superior to CT in detecting cortical involvement and multiple 
ischemic lesions correlating with cardioembolic stroke [18]. 
  Cerebral ischemia with hemorrhagic transformation has 
been associated to cardioembolic stroke. Hemorrhagic 
transformation occurs in up to 71% of cardioembolic strokes 
and 91% of hemorrhagic infarcts are caused by a cardiac 
embolism [16,20]. Hemorrhagic transformation has been 
traditionally explained by recanalisation of an occluded 
vessel to a damaged ischemic tissue and vessel walls. 
Recanalisation after 6 hours of ischemia and the detection of 
microbleeds on gradient-echo T2-weighted MRI are predic-
tors of hemorrhagic transformation [17,21]. 
  The presence of the hyperdense cerebral artery sign on 
non-contrast CT scanning (Fig. 1) [22], or the corresponding 
hyperintense artery sign on MRI [23], originated by an 
occluding thrombus, suggests the diagnosis of an embolic 
arterial occlusion that may be of cardiac origin if no arterial 
pathology is detected. 
  Early noninvasive vascular imaging of the cerebral and 
cervical arteries by ultrasonography or MRI/CT angiography 
can help to impugn a cardiac source of emboli. The detection 
of oscillating, homogenous, elastic mass-echos by CCD in an 
occlusion of the internal carotid artery suggests a thrombus 
of cardiac origin [24]. TCD has shown the capacity to detect 
early recanalisation of a stenotic or occluded artery in the 
territory of the infarct correlating with an embolic thrombus 
[25]. 
  TCD allows a first line non-invasive diagnosis of a right-
to-left shunt (RLS) caused by a patent foramen ovale (PFO) 
by detecting bubble signals in the middle cerebral artery 
(Fig. 2) after the injection of agitated saline in the antecubital  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Hyperdense artery sign on CT scan showing a thrombus in 
the middle cerebral artery. 
 
vein [26]. The magnitude of the RLS could have prognostic 
implications [27].  
  TCD can detect high intensity transient signals (HITS) 
indicating microembolism from an embolic condition. HITS 
have a strong correlation with arterial or cardiac sources of 
emboli in the acute phase of stroke and have an independent 
predictive value of poor outcome [28,29]. However HITS are 
more reliable from a carotid than from a cardiac source of 
embolism where they tend to disappear soon after the embo-
lic event and do not have a clear relation with the embolic 
risk [30]. 
LABORATORY TESTS 
  There are no diagnostic laboratory tests to identify 
cardioembolic stroke. Cardiac enzyme and troponins are 
routinely recommended in the acute phase of stroke in order 
to detect an underlying acute coronary syndrome [31]. 
Several efforts have been conducted towards the research of 
plasma biomarkers to diagnose the different subtypes of 
stroke and Brain Natriuretic Peptide (BNP) has been corre-
lated with cardioembolic stroke [32,33]. 
ELECTROCARDIOGRAPHIC MONITORING 
  Atrial fibrillation (AF) is the most common cause of 
cardioembolic stroke. Valvular AF has higher embolic risk 
than nonvalvular AF. Paroxysmal AF has a similar stroke 
risk than continuous AF. Suffering a stroke caused by lone 
AF boosts annual stroke risk from 0.5% to 12%. 
  Given the stroke risk and the clear benefit of warfarin 
over aspirin for secondary prevention, identification of atrial 
fibrillation, especially when occult, is warranted in the 
cardiac workup of ischemic stroke. 
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Electrocardiogram (ECG) 
  Most clinical practice guidelines include a standard 12-
lead ECG in the immediate evaluation of acute ischemic 
stroke and transient ischemic attack (TIA) [31]. Cardiac 
abnormalities either acute, like coexisting acute coronary 
syndrome, or reflecting chronic cardiac disease are prevalent 
in the acute phase of stroke.  
  ECG can diagnose the cause of stroke by identifying AF, 
coexisting acute myocardial infarction (MI) or chronic 
cardiac disease that may predispose to embolic sources. ECG 
is also necessary to detect common cardiac complications 
such as myocardial ischemia or cardiac arrhythmias in the 
acute phase of stroke. 
  ECG abnormalities are reported in 75-90% of stroke 
patients [34]. The most common findings include repolari-
zation and ischemic-like ECG changes. Most of these 
findings represent preexisting cardiac disease. After exclu-
ding those patients with underlying heart disease there is still 
up to one third of patients showing abnormalities like QT-
prolongation or nonspecific ST changes. The sensibility to 
detect ECG abnormalities is high but the specificity to detect 
acute myocardial infarction is very low [34].  
  Initial ECG has a detection rate for AF varying from 5 to 
25%, usually due to patients with already known AF [35]. 
Detection of new-onset AF is more infrequent, with rates 
around 4.8%. Douen et al. has shown that performance of 
serial ECG within the first 72 hours of acute stroke can 
increase detection almost 3-fold, half of the new-onset AF 
being detected on initial ECG and the rest on serial ECG 
assessments. This result is even more relevant as Holter 
monitoring was only able to detect AF in 50% of the new-
onset cases [36]. This result could be explained by the delay 
of 4.75 days in Holter monitoring. 
  ECG changes suggestive of acute MI such as ST changes 
may be a potential etiology. Left ventricular thrombus is 
found in 5% of patients with acute MI, in 11.5% of patients 
with anterior MI compared to 2.3% of MI in other sites [37]. 
The risk of cardioembolism can be as high as 6% in the next 
6 to 12 months [38]. 
  Some ECG changes such as unrecognized MI, p-wave 
abnormalities and left ventricular hypertrophy have been 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Right-to-left shunt detected by TCD with microbubbles in the middle cerebral artery. Cardiac Workup of Ischemic Stroke  Current Cardiology Reviews, 2010, Vol. 6, No. 3    179 
associated with increased risk of stroke. Ventricular arrhy-
thmias, concurrent MI and a prolonged QT interval have 
been associated with increased mortality in stroke patients 
[39]. 
Continuous Monitoring 
  Paroxysmal AF and continuous AF present a comparable 
risk of stroke. ECG may not detect transient arrhythmias. 
Clinical practice guidelines recommend continuous cardiac 
rhythm monitoring for hospitalized patients with acute stroke 
[31]. Telemetry monitoring during 48 hours in acute ische-
mic stroke patients detects between 4 to 8’4% of new onset 
paroxysmal AF not previously diagnosed by history or 
routine ECG [40,41]. 
  Although the rate of diagnosis of new-onset AF by 
telemetry may be low, continuous cardiac monitoring has 
prognostic implications in all stroke patients. Between 60-
65% of patients will develop conduction or rhythm abnor-
malities. Multivariate analysis shows that AF, atrioven-
tricular block, ST-changes and inverted T-waves predict 3 
month mortality independent of stroke severity, disability 
and age [42]. 
Holter Monitoring 
  Holter monitors are portable devices that record 
continuous data from 2 or 3 ECG leads during 24 or 48 
hours. There is no clear recommendation on routine Holter 
monitoring for unselected patients. There is considerable 
controversy regarding the use of routine Holter monitoring. 
Low detection rates and cost-effectiveness are arguments 
against its recommendation in routine workup in stroke units 
[43,44].  
  A recent review including studies with 736 participants 
analyzed Holter monitoring in acute ischemic stroke with a 
global rate of new-onset AF detection of 4.6% [45]. Reasons 
for low detection rates might be the inclusion of unselected 
patients and the variable duration and timing of monitoring. 
The results of the different studies reviewed suggest that 
early and more prolonged monitoring might improve detec-
tion rates [45]. 
  Holter monitoring can also be useful to identify  the 
subgroup of patients with characteristics associated with 
occult AF where extended cardiac monitoring could be 
effective. Wallman et al. described that >70 premature atrial 
beats per 24 hours predicts a 26% detection of AF when 
monitoring is extended to 7 days [46]. 
Event Recorders 
  Event loop recorders are external ambulatory devices that 
allow up to 30 days of cardiac rhythm recording.  
  Two prospective studies evaluated event recorders for 
diagnosing paroxysmal AF in stroke patients. Barthelemy et 
al. evaluated 60 consecutive stroke patients, 28 of them 
without etiology after the standard diagnostic procedures 
including Holter monitoring, event recorders revealed 
paroxysmal AF in 14.3% of them [47]. The duration of 
monitoring in this study ranged from 24 to 162 hours. 
Jaboudon et al. included 149 consecutive patients with 7-day 
ambulatory ECG monitoring detecting paroxysmal AF in 
5.7% of them [48]. 
  Prolonged monitoring has shown to improve the rates of 
detection [46]. Tayal et al. evaluated retrospectively 56 
consecutive patients with cryptogenic stroke or TIA with a 
Mobile Cardiac Outpatient Telemetry (MCOT) device 
during 21 days resulting in an AF detection rate of 23% [49]. 
  Implantable monitoring devices offer the advantage of 
more prolonged monitoring, up to 14 months, revealing a 
high incidence of recurrent AF [50,51] but to date we have 
not found any studies evaluating stroke patients. 
  An interesting study used a modified automatic sphyg-
momanometer to detect recurrent atrial fibrillation as an 
ambulatory self-screening method with sensitivity near 
100% and specificity near 91% [52]. 
Improving Paroxysmal AF Detection 
  Patient selection for cardiac monitoring is mandatory to 
improve cost-effectiveness of prolonged monitoring (Table 
2). Longer monitoring should be limited to patients with a 
high suspicion of cardioembolic stroke.  
Table 2.  Rates of New-Onset Atrial Fibrillation Detection 
Test Rate  %  Duration 
Initial ECG 
Serial ECG 
Holter 
Telemetry 
Event loop recorders 
 or other ambulatory 
devices 
4.8 
5.5 
4.6 
4- 8.4 
5.7 
14.3 
23 
 
72h 
24h 
48h 
24h 
4 days 
21 days 
 
 Suissa  et al. have recently published a predictive score to 
identify AF in patients who have suffered a stroke, Score for 
the Targeting of Atrial Fibrillation (STAF). The score 
calculates the sum of 4 items: age >62 (2 points), National 
Institutes of Health Stroke Scale (NIHSS) >8 (1 point), left 
atrial dilatation (2 points), absence of symptomatic intra or 
extracranial stenosis > 50% or clinic-radiological lacunar 
syndrome (3 points). A STAF score >5 identified patients 
with AF with 89% sensitivity and 88% specificity [53]. 
  Cryptogenic stroke with different arterial territories 
affected on neuroimaging, dilated left atrium in echocar-
diography, >70 premature atrial beats per 24 hours in Holter 
monitoring [46] and increased age suggest an occult AF as a 
cause of stroke and should warrant longer periods of 
monitoring.  
CARDIAC IMAGING 
  In many patients history, physical examination and ECG 
may reveal a cardiac source of emboli. If embolic stroke is 
suspected and extra and intracranial cerebral vessel imaging 
have not revealed an arterial ipsilateral stenosis and routine 
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imaging is necessary to detect cardiac sources of emboli 
originated by abnormalities of cardiac structure (Table 3). 
Table 3.  Cardiac Sources and Embolic Risk 
High risk 
 
Atrial 
- Atrial fibrillation 
- Atrial flutter 
- Sick sinus syndrome 
- Left atrial thrombus 
 
Valvular 
- Mitral valve stenosis 
- Prosthetic cardiac valve 
- Left ventricular thrombus 
- Acute myocardial infarction 
- Dilated cardiomyopathy 
 
Vegetations 
- Infective endocarditis 
- Marantic endocarditis 
 
Complex aortic arch atheroma 
 
Tumours 
- Myxoma 
- Papillary fibroellastoma 
- Mestastasic tumours 
Low or uncertain risk 
 
Interatrial septal abnormalities 
- Patent Foramen Ovale 
- Atrial-septal aneurysm 
 
Pulmonary arteriovenous malformation 
 
Spontaneous echo contrast (“smoke”) 
 
Mitral valve prolapse 
Mitral annular calcification 
Aortic valve sclerosis/stenosis 
 
Valvular strands 
 
  Left heart thrombus is considered a high-risk source and 
requires blood stasis to develop. Left atrial thrombus (LAT) 
is usually observed in AF or mitral stenosis. LAT can also 
develop in myocardial or valvular disease [54]. Left 
ventricular thrombus is more frequently associated to MI. A 
meta-analysis calculated a risk of stroke after MI of 12.2 per 
1000 MI at 30 days [55]. Ventricular aneurysms develop 
mural thrombi with persistent embolic risk [56]. Dilated 
cardiomyopathy has an annual risk of embolisation of 1-
3.5% rising to 9% after suffering a stroke [57]. Intracavitary 
thrombus conveys a high risk of embolisation and favours 
early anticoagulation [38]. 
  Vegetations related to infective or non-infective endo-
carditis are also high-risk conditions. Infective endocarditis 
has a 15-20% incidence of ischemic stroke, with higher risk 
during the first week or with mitral involvement [58]. 
Marantic or non-bacterial thrombotic endocarditis is usually 
associated to neoplastic, immunological or other debilitating 
diseases with a high risk of embolism [59]. 
  Prosthetic valves either biological or mechanical have a 1 
to 4% annual risk of embolisation, being this risk higher in 
mitral prosthetic valves, 2 to 3.5% annually, and amplified 
by AF [60]. 
  Complex aortic arch atheroma (CAA) protruding 4mm 
has a relative risk of recurrent stroke of 1.6 to 4.3, and the 
risk increases if the plaque is ulcerated, non-calcified or 
mobile [61]. 
  Other findings such as PFO and atrial septal aneurysm 
(ASA), pulmonary shunt, spontaneous echo contrast (SEC), 
valvular strands, valvular calcification and mitral valve 
prolapse presumably have a lower risk and are classified as 
medium or uncertain risk cardiac sources of emboli [38]. 
Echocardiography 
  There is controversy regarding the indication and the 
optimal echocardiographic approach in the cardiac workup 
of ischemic stroke. The European Stroke Organization 
guidelines recommend the use of echocardiography in 
selected patients while the American Stroke Association 
guidelines do not make any clear recommendation on the use 
of echocardiography [62,31]. 
  There are pros and cons to TTE and TEE. TTE is easier 
to perform, not invasive, widely available and cheaper than 
TEE. However it is clearly less sensitive for the detection of 
unknown cardiac sources of emboli. TEE has the disadvan-
tage of being invasive, more expensive and requires more 
training to be performed adequately. 
  TEE identifies possible cardiac sources of embolism in 
more than 50% of patients without clinically known heart 
disease [63]. TTE with agitated saline-injection may reach a 
25% rate of success but drops to 10% without saline-
injection. The sensibility for the detection of left ventricular 
thrombi is similar but the detection of LAT, PFO and 
vegetations favors TEE [38]. 
  New techniques such as second-harmonic are improving 
the sensitivity of TTE reaching 62.5% compared to the 90% 
of TTE diagnosing PFO. However, PFO can be diagnosed by 
TCD non-invasively with agitated-saline injection detecting 
RLS with comparable diagnostic accuracy to TEE [64, 65]. 
  TEE is considered safe with a 0.025 complication rate 
[66] but cases of paradoxical air emboli have been published 
[67] and the risks of hypotension during the procedure 
should not be underestimated in acute stroke patients [39]. 
Optimal Diagnostic Approach 
  There is no data to support an optimal approach in the 
echocardiographic evaluation of stroke patients. Few studies 
evaluate patient selection in order to improve the diagnostic 
and therapeutic yield of echocardiography. 
  While the superiority of TEE is clear some authors focus 
on the impact in clinical decisions. The diagnosis of throm-
bus, infectious endocarditis and cardiac tumours will have 
therapeutic implications but other conditions such as PFO, 
ASA, CAA and SEC have uncertain treatment strategies. 
  The presence of heart disease may be a major condi-
tioning as TTE has superior yield close to 25% if heart 
disease is present [38]. While age could be used to select 
patients, several studies have concluded that it should not be 
used as an exclusion criterion in the selection of patients for 
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 Strandberg  et al. evaluated 441 unselected stroke patients 
with TEE detecting a cardiac source of embolism in 56% of 
the patients. After excluding patients with known heart 
disease or AF, analysis of the patients in sinus rhythm and 
without heart disease revealed that 8% of them suffered a 
change of therapy due to TEE results [69]. 
 De  Bruijn  et al. evaluated 231 cryptogenic stroke patients 
with TTE and TEE. TEE detected a cardiac source of emboli 
with indication for oral anticoagulation in 16% of the 
patients [68]. 
 Harloff  et al. included 503 consecutive patients with 
acute brain ischemia. All patients received routine diagnos-
tics and TEE. The patients were classified by TOAST crite-
ria into atherotrombotic, cardioembolic, small vessel disease, 
stroke of other known etiology and undetermined or 
cryptogenic stroke. In patients with large artery, small vessel 
and cardiembolic stroke or stroke of other known causes 
TEE had a low therapeutic yield of 3% while in patients with 
cryptogenic stroke TEE revealed a cardiac source which 
prompted anticoagulant treatment in 30% of the patients 
[70].  
  These results support the use of TEE in patients who are 
candidates for oral anticoagulants after routine diagnostics 
cannot find an etiology. Arguably in these studies either no 
details are given about the findings that led to anticoagu-
lation therapy or the findings that prompted a change do not 
have a clear recommendation for anticoagulation. The thera-
peutic yield of TEE is a matter of debate and needs more 
data to recommend an optimal approach. 
CONCLUSIONS 
  The diagnosis of cardioembolic stroke relies on the detec-
tion of cardiac sources of embolism and the absence of other 
more plausible etiologies. There are no clear recommen-
dations on the optimal and most cost-effective approach 
although the high prevalence of the disease and its prog-
nostic implications warrants a cautious evaluation. 
  We propose a systematic approach based on general 
accepted practice with slight modifications based on articles 
reviewed and expert opinion (Fig. 3) [31, 39, 62].  
  Patient selection is the clue for a cost-effective approach 
to the diagnosis of cardioembolic stroke. 
  All acute ischemic stroke patients must receive a com-
plete cardiovascular history and physical examination with 
accurate cardiac evaluation in order to detect already known 
or unknown underlying heart disease. A proper neurological 
evaluation should reveal the suspicion of embolic stroke. 
  All stroke patients should be evaluated with initial ECG 
and receive serial ECG and 48 hour telemetry to identify 
potential sources of embolism. ECG and telemetry are cost-
effective in all stroke patients as they also have prognostic 
implications detecting cardiac complications in the acute 
phase of stroke. 
  Neuroimaging, preferably with MRI, may help reveal 
patterns of ischemia suggestive of embolic stroke of cardiac 
origin. 
Ultrasonography of the intracranial and extracranial arteries 
or MRI or CT based angiography must be done in all stroke 
patients to rule out large vessel disease. TCD may be used 
first-line to diagnose RLS. HITS monitoring may be useful 
in selected patients. 
  There is no reason for further cardiological studies in 
those patients not eligible for oral anticoagulation. Patients 
with lacunar stroke or with symptomatic 50% ipsilateral 
artery stenosis may not need extended cardiac monitoring or 
imaging. Patients with symptomatic intracranial stenosis 
should be reevaluated later in time to rule out recanalisation 
suggestive of an embolic thrombus. 
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  All patients with undetermined stroke after these studies 
with an embolic pattern should receive TTE followed by 
TEE if the previous is non-diagnostic. In patients without 
previous heart disease, with RLS on TCD or in  young 
patients where other sources of emboli such as cardiac 
tumours or PFO are more relevant it may be more cost-
effective to directly proceed with TEE. 
  Patients with no etiology and with evidence of embolic 
stroke where paroxysmal AF is suspected should receive 
prolonged rhythm monitoring with Holter monitors and if the 
suspicion is high because of age, neuroimaging results, 
echocardiographic and Holter findings, prolonged cardiac 
rhythm monitoring with other devices should be considered. 
  More research with prospective data is needed to evaluate 
an appropriate cost-effective approach.  
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